RT Journal Article
SR Electronic
T1 SARS-CoV-2 seroprevalence in asymptomatic or mild symptomatic people and symptomatic patients with negative PCR results: The hidden perspective in epidemiological reports
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.11.21260336
DO 10.1101/2021.07.11.21260336
A1 Hajiahmadi, Nazila
A1 Mojtahedzadeh, Faezeh
A1 Yari, Atefeh
A1 Tat, Mahdi
A1 Soleimanjahi, Hoorieh
A1 Jamehdar, Saeid Amel
A1 Jafari, Mitra
A1 Asli, Samira
A1 Dorostkar, Rohollah
A1 Nazemipour, Maryam
A1 Mansournia, Mohammad Ali
A1 Bamdad, Taravat
YR 2021
UL http://medrxiv.org/content/early/2021/07/14/2021.07.11.21260336.abstract
AB Background SARS-CoV-2 has led to the current pandemic of respiratory disease. The reports of confirmed COVID-19 cases based on molecular tests do not completely cover the total number of infected people. These reports do not include the asymptomatic or mildly symptomatic patients and also the patients with false-negative RT-PCR results, while the infection is contagious in all of these conditions.Objective In this study, we tried to improve our conception of the hidden perspective of SARS-CoV-2 in epidemiological reports.Methods From May 30 to June 17, 2020, blood samples were collected from two groups of people: asymptomatic or mild symptomatic volunteer participants and severe symptomatic hospitalized patients with negative PCR results. Detection of SARS-CoV-2 antibody was done with ELISA kit targeting N or S proteins.Results Totally 716 samples from volunteer participants and 81 samples from symptomatic hospitalized patients with negative PCR were evaluated. The test performance-adjusted seroprevalence (95% CI) of SARS-CoV-2 anti-N IgG was 17.3% (8.8%, 25.8%) for volunteers and 25.5% (12.8%, 39.7%) for anti-N and S IgM in hospitalized group. There was an association between high-risk occupations, high-risk behaviors, or symptomatic diseases with positive SARA-Cov-2 N antibody results. Among anti-N positive infected individuals, 49.2% (21.4%, 78.8%) were anti-S positive.Conclusion The results showed that SARS-COV-2 infection occurs in asymptomatic or mildly symptomatic individuals, but in more than half of them, the produced antibody is not protective. Findings of hospitalized patients also showed that the combination of IgM assay with real-time PCR improves the detection of the disease by more than 25% in negative molecular cases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported financially by a grant of Research and Technology (National Institute of Genetic Engineering and Biotechnology) and school of medical sciences of Tarbiat Modares University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committee of Tarbiat Modares University (IR.MODARES.REC 1399.009) and Baqiyatallah University of Medical Sciences (IR.BMSU.REC.1399.299) approved the study. Written informed consents were obtained before sampling.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data mentioned in the article are available.